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Use of antimicrobial resistance information
and prescribing guidance for management
of urinary tract infections: survey of general
practitioners in the West Midlands
Dean Ironmonger1*, Obaghe Edeghere1, Savita Gossain2 and Peter M. Hawkey2,3*
Abstract
Background: There is a marked variation in both antibiotic prescribing practice and urine sampling rates for
diagnostic microbiology across general practices in England. To help understand factors driving this variation, we
undertook a survey in 2012/13 to determine sampling protocols and antibiotic formularies used by general
practitioners (GPs) for managing urinary tract infections (UTIs) in the West Midlands region of England.
Method: Cross-sectional survey of all eligible general practices in the West Midlands region of England undertaken
in November 2012. GPs were invited to complete an online survey questionnaire to gather information on policies
used within the practice for urine sampling for microbiological examination, and the source of antibiotic formularies
used to guide treatment of UTIs. The questionnaire also gathered information on how they would manage five
hypothetical clinical scenarios encountered in the community.
Results: The response rate was 11.3 % (409/3635 GPs), equivalent to a practice response rate of 26 % (248/950).
Only 50 % of GPs reported having a practice policy for urine sampling. Although there was good agreement from
GPs regarding collecting specimens in scenarios symbolising treatment failure (98 %), UTI in an adult male (98 %)
and asymptomatic UTI in pregnancy (97 %), there was variation in GPs requesting a specimen for the scenarios
involving a suspected uncomplicated urinary tract infection (UTI) and an asymptomatic catheterised elderly patient;
with 40 and 38 % respectively indicating they would collect a specimen for microbiological examination.
Conclusion: Standardised evidence based clinical management policies and antibiotic formularies for GPs should
be readily available. This will promote the rational use of diagnostic microbiology services, improve antimicrobial
stewardship and aid the interpretation of ongoing antimicrobial resistance surveillance.
Keywords: Antimicrobial resistance, Antibiotic prescribing, Urinary tract infection, Community sampling
Background
Antimicrobial resistance (AMR) is a serious threat to
health and the inappropriate use of antibiotics is central
to the development of antibiotic resistance [1]. The UK
five year AMR Strategy recommends the strengthening
of AMR surveillance to inform local prescribing and
enable the monitoring of the impact of interventions
aimed at reducing the burden of antibiotic resistance [2].
Antimicrobial susceptibility data from diagnostic
microbiology laboratories can be used for surveillance to
monitor trends in AMR [3]. This data is based on speci-
mens submitted to laboratories and may be subject to
selection bias due to over sampling of clinical specimens
from patients with initial treatment failures, complicated
clinical histories or severe infections [4, 5]. An English
study in 2004 found a wide range for sampling urine
specimens, from 29 to 266 urine samples/1000 patients/
year [5]. A Welsh study in 2006 found a similar range,
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with sampling rates varying from 0.6 to 237.3 urine sam-
ples/1000 patient/year [4], suggesting substantial vari-
ability in local sampling policies.
Studies in England and the United States have shown
urine is the most frequent specimen sent for microbio-
logical examination from non-hospitalised patients and
urinary tract infection (UTI) is one of the most common
diagnoses that results in antibiotic prescribing [6, 7]. In
England in 2009, there was a fivefold difference in anti-
biotic prescribing volume between general practices [8],
with 74 % of antibiotic prescribing occurring in commu-
nity settings in 2014 [9].
There is a linear relationship between trends in anti-
biotic consumption and resistance [10, 11]. Variation in
antibiotic prescribing rates in general practices have
been shown to be negatively associated with variation in
observed antibiotic resistance in the local population
[12, 13]. National guidance for the management of infec-
tions and prescribing in the community has not reduced
the variation in antibiotic prescribing across general
practices in the UK, particularly in the management of
upper respiratory and urinary tract infections [14].
In order to better understand some of the organisational
and behavioural factors driving this variation in both anti-
biotic prescribing and specimen sampling for diagnostic
microbiology, and thereby aid the interpretation of routine
AMR surveillance data, we conducted a survey among
general practitioners (GPs) in the West Midlands to
examine the use of diagnostic microbiology services and
empirical treatment for patients presenting with suspected
UTI, and determine the source of prescribing advice.
Methods
Setting/population
The West Midlands is one of nine English administrative
regions and in 2012 there were 950 general practices
with a total of 3635 general practitioners responsible for
5.8 million registered patients [15]. Each practice had an
average of 4 GPs with an average practice list size of just
over 6,000 patients and 73 % of practices were located in
Local Authority (English local administrative unit) areas
designated as urban [15].
Survey of GPs in the West Midlands
We conducted a cross-sectional survey during November
2012 to February 2013 among GPs providing community
healthcare in the West Midlands. Community healthcare
was defined as ambulatory primary healthcare delivered
by registered GPs working within practices in the West
Midlands.
The survey questionnaire was developed using a tem-
plate from an earlier Welsh study [4] and consisted of
17 questions divided into 3 sections (Additional file 1).
Section 1 collected demographic data related to the
practice and GPs. Section 2 elicited information on
policies employed for the management of UTI, with
questions on the use and source of prescribing formular-
ies, existence of practice policies for urine sampling;
how microbiological results influenced antibiotic pre-
scribing; and an estimate of the proportion of patients
clinically suspected as having a UTI for which urine
specimens were requested.
Section 3 described five hypothetical clinical scenarios
(A to E) involving potential UTI presentations and GPs
were asked whether they would request a specimen and/
or prescribe antibiotics empirically (Table 1). Section 4
captured free text comments from the respondents.
We obtained a sampling frame of all eligible prac-
tices and GPs from NHS Primary Care Trusts (PCTs)
(healthcare commissioners, now replaced by Clinical
Commissioning Groups). This sampling frame contained
email addresses of GP Practice Managers within the
localities of 10 of the 17 PCTs in existence at the
time of the study, with the remaining PCTs agreeing
to use their existing networks to disseminate the sur-
vey invitation.
In October 2012, five GP practices were randomly
selected from the sampling frame and invited to pilot
the questionnaire. Two of these practices, consisting of
20 registered GPs participated in the pilot and the feed-
back received was used to improve the questionnaire.
The final questionnaire was produced and hosted on-
line using SelectSurvey.net (ClassApps, USA). No
sample size calculation was undertaken as all eligible
practices were invited to complete the survey via email
during November 2012. One email reminder was sent
Table 1 Clinical scenarios presented to survey participants
Scenario A: Treatment failure in a young woman
A 20 year old lady re-attends surgery and complains that the loin pain
and frequent urination symptoms reported to you the previous week
had worsened despite finishing a complete course of trimethoprim
(no sample was taken previously).
Scenario B: Probable uncomplicated UTI
A 43 year old woman complains of pain passing urine and frequency.
She feels well otherwise and has not previously been treated for a UTI.
Scenario C: Probable UTI in an adult male
A 51 year-old man attends your surgery complaining of pain passing
urine and perineal tenderness. On examination you find suprapubic
tenderness and a temperature of 38.5 C is measured.
Scenario D: Possible asymptomatic UTI in pregnancy
During a routine antenatal clinic an 18 year old girl who is 20 weeks
pregnant produces a cloudy urine sample. She reports no symptoms
or discomfort. The urine dipstick tests positive for nitrite but negative
for leukocytes and protein.
Scenario E: Catheterised asymptomatic elderly female
You visit an 82 year old female in a nursing home. She is catheterised,
afebrile and has no symptoms but the staff inform you that the urine is
cloudy.
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out to practices in January 2013 and the survey closed in
February 2013.
Statistical analysis
The survey data was collated using Microsoft Excel
(Microsoft Redmond, WA). Categorical variables were
summarised as counts and proportions with differences
between male and female GPs tested using a two-
proportion Z test with p < 0.05 considered statistically
significant. All statistical analyses were performed using
STATA v12 (StataCorp, USA). All free text comments
were analysed by thematic analysis.
Results
The response rate was 11.3 % (409/3635 GPs) equivalent
to a practice response rate of 26 % (248/950). The age
group distribution of respondents were 10 % aged under
35 years, 31 % aged 35–45 years, 44 % were aged 46–55
years and 16 % were over 55 years old. Fifty-four percent
of the GPs were female (222/409) and a majority (62 %)
of responders were qualified for 20 or more years. The
age and sex of the responders was broadly comparable
with the demographic profile of all GPs in the West
Midlands.
Use of prescribing formularies
Eighty-six percent (314/366) of respondents reported
that they use antibiotic prescribing formularies to guide
prescribing decisions. The majority of these respondents
(73 %; 269/366) stated that they used a formulary pro-
vided by their PCT; with 45 (12 %) reporting using more
than one formulary (Table 2).
Thirty-four percent (123/366) had reviewed compli-
ance with existing policy for the management of UTI in
the last 12 months prior to the survey.
Influence of laboratory antimicrobial susceptibility results
on antibiotic prescribing
Two hundred and fifty (70 %) respondents indicated that
susceptibility results ‘always’ or ‘frequently’ influenced
their antibiotic prescribing decisions for UTI. There was
a significant difference (79 vs. 68 %; p = 0.021) between
female and male GPs in the use of laboratory results to
guide prescribing following treatment failure (Table 3).
Only 6/362 (2 %) GPs reported that laboratory results
infrequently or never influenced their prescribing in the
case of reported resistance to initial therapy.
Factors influencing GPs decision to send urine specimens
for diagnostic microbiology
Half (183/366) of the respondents reported that their
practice had a policy to guide urine sampling for micro-
biological examination.
There was considerable variation among respondents
regarding the approximate proportion of clinical consul-
tations for suspected UTI that resulted in a urine speci-
men being sent for diagnostic microbiology (median
50 %, IQR 30 to 75 %).
Clinical scenarios
In scenarios A, C and D (Table 4) the majority of GPs
would submit a urine specimen for diagnostic microbiol-
ogy (98, 98 and 97 % respectively), which is in-line with
Public Health England (PHE) national guidance [16]. In
scenario B, 40 % of GPs indicated that they would sub-
mit a urine specimen for microbiological testing, even
though PHE guidance recommends samples should not
be sent for examination routinely for uncomplicated
UTI in female adults <65 years of age. There was a
difference in urine sampling between genders for the
catheterised asymptomatic elderly female scenario
(scenario E) with 32 % of male GPs indicating they
would submit a sample, compared to 43 % of female
GPs (p = 0.034), whereas PHE guidance recommends
that urine specimens should only be sent for examin-
ation in catheterized patients when features of sys-
temic infection are observed.
The majority of GPs follow PHE guidance [16] by pre-
scribing an antibiotic empirically for probable treatment
failure (scenario A, 80 %), suspected uncomplicated UTI
(scenario B, 78 %) and probable UTI in a male adult
(scenario C, 98 %) (Table 4).
There was significant variation between male and fe-
male GPs for prescribing antibiotics in the suspected
UTI in pregnancy scenario (scenario D) where 43 % of
female GPs would prescribe compared to 30 % of male
GPs (p = 0.0123).
One hundred and four (104/409, 25 %) GPs entered
additional free text comments.
Table 2 Reported source of antibiotic prescribing formularies/
prescribing guidance used by survey respondents (N = 352)
Source of antibiotic formulary Number using
sourceb
Primary Care Trusta 269
British National Formulary 46
Local area prescribing committee 17
Practice formulary 13
Local NHS Microbiology department 6
NHS Hospital/Trust 4
Health Protection Agency (now part of Public
Health England)
3
NICE 1
aOn April 2013, PCTs were replaced by Clinical Commissioning Groups
bNote some respondents mentioned more than one source
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The main themes emerging from the analyses was the
use of urinary dipstick test to investigate UTI in some
of the scenarios presented, particularly scenario A
(55/104, 53 %); the need to gather additional clinical
information (15/104,14 %); inclination to send urine
specimens by default (14/104, 13 %), and influence of
the timing of the consultation in determining whether
to take a specimen due to specimen transport issues
(8/104, 8 %).
Discussion
We consider this to be the first study examining the role
of specific organisational and behavioral factors in the
observed variation of urine sampling for diagnostic
microbiology, and antibiotic prescribing for patients with
UTIs among GPs serving a region of England. We found
that the existence of a practice policy to guide sampling
for diagnostic microbiology varied considerably across
the region, as did the proportion of GPs that would sub-
mit a specimen and/or prescribe an antibiotic in a num-
ber of clinical scenarios. Understanding GPs knowledge
and attitude towards the management of UTI within a
region will aid interpretation of local AMR surveillance
data, help guide appropriate use of regional laboratory
resources and inform targeted interventions to promote
antimicrobial stewardship.
A commonly cited issue in interpreting routinely re-
ported AMR data from community settings is sampling
bias, which may lead to observed levels of resistance that
overestimate the burden of AMR in the general popula-
tion. Only half of the GPs who responded reported hav-
ing a practice policy to guide clinical sampling for
diagnostic microbiology. There was considerable vari-
ation in the estimated proportion of clinical consulta-
tions for suspected UTI in which a urine specimen is
sent for diagnostic microbiology. However we found that
the response was broadly consistent for the scenarios in-
volving: treatment failure, probable UTI in an adult male
and possible UTI in pregnancy, and therefore using clin-
ical scenarios may provide a more reliable insight into
GP sampling practice than relying on a general view of
GPs prescribing habits [4].
We found 40 % of GPs would submit a sample for
diagnosis of the most commonly encountered presenta-
tion of uncomplicated UTIs, although PHE guidance
recommends not sending urine samples for this presen-
tation [16, 17]. This is a similar finding to a study in
Wales in 2006 that found 56 % of randomly selected
GPs would submit a urine specimen for probable un-
complicated UTI [4]. Also PHE guidance for manage-
ment of UTIs in catheterised patients recommends that
a urine sample should only be sent if there are signs of
systemic infection [16], however 38 % of respondents
would send a urine specimen in the catheterised asymp-
tomatic elderly female scenario (Table 4). These results
indicate non-compliance with guidance for certain clin-
ical scenarios and a degree of inappropriate microbio-
logical testing. A German study in 2005 concluded that
most patients in their study were not treated according
to current guidelines and for half the patients the deci-
sion to prescribe an antibiotic or the antibiotic pre-
scribed was inappropriate [18].
It is plausible that this non-compliance with the
guidance may be driven by ambiguity in the advice
provided by existing national guidance. The National
Institute for Health and Care Excellence (NICE)
Clinical Knowledge Summaries advise that a urine
sample should be sent to the laboratory for all
women with suspected UTI associated with visible or
non-visible haematuria [17]; however PHE guidance
advises that urine samples should not be routinely
submitted from women <65 of age, and if there are
signs of UTI, including haematuria, then only empirical
Table 3 Influence of laboratory results on antibiotic prescribing decision (number that would prescribe/number of respondents)
Male Female
Always Frequently Infrequently Never Always Frequently Infrequently Never
General prescribing 22 % (37/167) 46 % (77/167) 25 % (41/167) 7 % (11/167) 21 % (40/190) 51 % (97/190) 22 % (42/190) 6 % (12/190)
In the case of a treatment
failure
68 % (114/168) 29 % (49/168) 2 % (3/168) 1 % (1/168) 79 % (154/195) 19 % (38/195) 1 % (2/195) 1 % (1/195)
When resistance is reported
to initial prescribed agent
81 % (136/168) 16 % (27/168) 2 % (4/168) 1 % (1/168) 86 % (168/195) 13 % (26/195) 1 % (1/195) 0 % (0/195)
Table 4 Count and percentage of GPs requesting urine samples
and prescribing antibiotics for each clinical scenario
Clinical scenarios Number (%) of
GPs requesting
a specimen
Number (%) of GPs
that would prescribe
an antibiotic
A. Treatment failure in a young
women
344/352 (98 %) 284/353 (80 %)
B. Probable uncomplicated UTI 144/359 (40 %) 270/345 (78 %)
C. Probable UTI in an adult male 348/354 (98 %) 344/352 (98 %)
D. Possible asymptomatic UTI in
pregnancy
341/353 (97 %) 129/352 (37 %)
E. Catheterised asymptomatic
elderly female
134/354 (38 %) 5/348 (1 %)
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treatment should be given [16]. We recommend that these
guidelines are reviewed so unambiguous evidence based
guidance is made available to GPs.
Whilst acknowledging the importance of autonomy in
clinical decision making, there is value in developing
and utilising standardised, evidence based sampling pol-
icies to ensure that diagnostic and treatment decisions
are both clinically effective and cost-effective [5]. In-
creasingly limited healthcare resources make a compel-
ling case for standardising sampling policies, but this
will only be achieved with consensus between microbiol-
ogists, community clinicians and policy makers.
The majority of respondents in our survey used local
prescribing formularies produced by their PCTs. As
PCTs were abolished at the end of March 2013 and re-
placed with Clinical Commissioning Groups (CCGs), we
are unsure whether these formularies have been updated
and are still being utilised. We recommend that CCGs
work with their GP practices to review and update exist-
ing formularies.
A small proportion of respondents (14 %) indicated
that they do not use a prescribing formulary to guide
treatment decisions. We cannot tell from our survey if
the non-utilisation of a formulary by these GPs results in
inappropriate prescribing but we recommend that this
issue be routinely assessed through the regular auditing
and feedback of individual prescribing patterns and im-
plementation of other interventions to address inappro-
priate prescribing as part of a wider antimicrobial
stewardship programme.
The symptoms of UTI are often distressing to the pa-
tient, requiring immediate empirical therapy [19]. In our
clinical scenarios most GPs would prescribe an antibiotic
empirically for scenarios A, B and C (Table 4), which is
in-line with national PHE guidance [16]; although it was
surprising to find that a fifth of GP respondents would
not prescribe an antibiotic in the treatment failure sce-
nario (scenario A) given the presence of worsening
symptoms.
Just over a third of our survey respondents indicated
that they would prescribe an antibiotic for a suspected
asymptomatic UTI in pregnancy (scenario D); even
though national guidance recommends that treatment
should only be considered after bacteruria is confirmed
by culture [16].
We found the gender of the GP was a factor in the re-
sponses to some of the survey questions, with a greater
proportion of female GPs reporting being influenced by
laboratory results, taking specimens and prescribing in
scenarios D and E.
A possible explanation may be differences in patient
empathy with particular patients groups or difference in
the desire to meet patient expectations [20]. A large
English study in 2009 found a higher proportion of male
GPs prescribing antibiotics in the community, and sug-
gested male GPs perceive a greater pressure from pa-
tients to prescribe [8]. We therefore suggest that further
behavioural studies are required to better understand
variation in prescribing between genders and help in-
form the design of interventions aimed at changing pre-
scribing habits.
There were some limitations to our study. The low re-
sponse rate raises the possibility of non-response bias
and its potential effect on the external validity of our
study. We believe any effect on our estimates and the
generalisability of our findings is low given that the
demographic profile of our respondents is similar to that
of all GPs in the West Midlands. In the free text com-
ments, 3 GP respondents indicated that they may delay
prescribing in some of the clinical scenarios; however
the ‘yes’ or ‘no’ response options to these questions pre-
vented the capture of this information.
Our analyses and interpretation of the free text com-
ments may not be representative of the cohort of re-
spondents as the number of comments was relatively
small. However emerging themes from the analysis of
these comments suggests that some GPs may be more
inclined to send urine specimens by default. This needs
to be explored further using alternative qualitative re-
search methods such as focus groups.
For our next steps we intend to survey CCGs to deter-
mine whether antibiotic prescribing formularies devel-
oped by the PCTs are still being used and updated since
the abolition of PCTs. We are also currently exploring
the use of mobile device technologies to deliver timely
localised AMR surveillance data and national prescribing
guidance directly to clinicians in community settings
and healthcare commissioners to support the manage-
ment of UTI.
Conclusion
The delivery of clinical care of consistent high quality
will benefit from the implementation of antimicrobial
stewardship programmes in community settings that in-
clude prescribing formularies based on local AMR sur-
veillance and unambiguous national guidance on the
management of infections. These, and policies to guide
clinical specimen sampling will also facilitate the cost-
effective use of available laboratory, and other finite
healthcare resources.
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